The Thematic Institute of molecular and structural biology of the French Alliance for life science (Aviesan) is programming a 2 days symposium dedicated to RNA biology and applications, that is a very active field with emerging topics.
Coding and non-coding RNAs are today central players in biology and medicine. RNA binding proteins act as modulators of RNAs functions, dysregulated RNA-protein interactions being linked to human pathologies, leading for example to misfolding or aggregations in membraneless organelles. In addition to human RNAs, bacterial RNAs and RNA viruses, are regarded as drug targets.
Epitranscriptomics, with modifications found in all RNAs and associated proteins have also come to the focus of intense research revealing their roles in many aspects of RNA biology and diseases. Finally, RNA medicines are actively developed for different therapeutic applications. RNA-based drugs are coming of age as a consequence of the improved knowledge of RNA biology combined with the development of sophisticated technologies.
This symposium will take place in Paris, on February 2-3 2023 end in Amphi Buffon, 15 Rue Hélène Brion, 75013 Paris. The meeting is built around different scientific sessions, namely RNA therapeutics, RNA/RNP biogenesis and structure, RNA modifications and new technological developments. The meeting is for structural, molecular and cellular biologists to have an overview of the latest results and concepts that are currently under development in the field.
Chargement... 
